The high-affinity IgE receptor (FcεRI) blocks apoptosis in normal human monocytes

Journal of Clinical Investigation

Volumn 105, Issue 2, 2000, Pages 183-190

  Katoh, Norito ^a,b   Kraft, Stefan ^a   Weßendorf, Jörg H M ^a   Bieber, Thomas ^a,b  

^a UNIVERSITY OF BONN   (Germany)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; IMMUNOGLOBULIN E RECEPTOR;

APOPTOSIS; ARTICLE; ATOPIC DERMATITIS; CELL CULTURE; CELL DIFFERENTIATION; CELL SURVIVAL; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL;

EID: 0033966524     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI6895     Document Type: Article

References (48)

1. Mangan, D.F., Mehgenhagen, S.E., and Wahl, S.M. 1993. Apoptosis in human monocytes: possible role in chronic inflammatory diseases. J. Periodontol. 64:461-466.
2. Lagasse, E., and Weissman, L. 1997. Enforced expression of Bcl-2 in monocytes rescues macrophages and partially reverses osteopetrosis in op/op mice. Cell. 89:1021-1031.
3. Mangan, D.F., Welch, G.R., and Wahl, S.M. 1991. Lipopolysaccharide, tumor necrosis factor-α, and IL-1β prevent programmed cell death (apoptosis) in human peripheral blood monocytes. J. Immunol. 146:1541-1546.
4. Kiener, P.A., et al. 1995. Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes. J. Immunol. 5:4917-4925.
5. Sallusto, F., and Lanzavecchia, A. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179:1109-1118.
6. Cohen, J.J., Duke, R.C., Fadok, V.A., and Sellins, K.S. 1992. Apoptosis and programmed cell death in immunity. Annu. Rev. Immunol. 10:267-293.
7. Bratton, D.L., et al. 1995. Granulocyte macrophage colony-stimulating factor contributes to enhanced monocytes survival in chronic atopic dermatitis. J. Clin. Invest. 95:211-218.
8. Maurer, D., et al. 1994. Expression of functional high affinity immunoglobulin E receptors (FcεRI) on monocytes of atopic individuals. J. Exp. Med. 199:745-750.
9. Maurer, D., et al. 1995. The high affinity IgE receptor (FcεRI) mediates IgE-dependent allergen presentation. J. Immunol. 154:6285-6290.
10. Bieber, T. 1996. FcεRI on antigen-presenting cells. Curr. Opin. Immunol. 8:773-777.
11. Stingl, G., and Maurer, D. 1997. IgE-mediated allergen presentation via Fc epsilon RI on antigen-presenting cells. Int. Arch. Allergy. Immunol. 113:24-29.
12. Wang, B., et al. 1992. Epidermal Langerhans cells from normal human skin bind monomeric IgE via FcεRI. J. Exp. Med. 175:1353-1365.
13. Maurer, D., et al. 1996. Peripheral blood dendritic cells express FcεRI as a complex composed of FcεRIα- and FcεRIγ-chains and can use this receptor for IgE-mediated allergen presentation. J. Immunol. 157:607-616.
14. Jürgens, M., Wollenberg, A., Hanau, D., de la Salle, H., and Bieber, T. 1995. Activation of human epidermal Langerhans cells by engagement of the high affinity receptor for IgE, FcεRI. J. Immunol. 155:5184-5189.
15. Keegan, A.D., and Paul, W.E. 1992. The multichain immune recognition receptors (MIRR). Immunol. Today. 13:63-65.
16. Reischl, I.G., et al. 1996. Function and regulation of FcεRI expression on monocytes from non-atopic donors. Clin. Exp. Allergy. 26:630-641.
17. Borish, L., Mascali, J.J., and Rosenwasser, L.J. 1991. IgE-dependent cytokine production by human peripheral blood mononuclear phagocytes. J. Immunol. 146:63-67.
18. Katoh, N., and Bieber, T. 1998. FcεRI mediates production of proinflammatory cytokines by human monocytes and monocyte-derived dendritic cells. J. Invest. Dermatol. 110:647.
19. Doherty, D.E., Haslett, C., Tonnesen, M.G., and Henson, P.M. 1987. Human monocyte adherence: a primary effect of chemotactic factors on the monocyte to stimulate adherence to human endothelium. J. Immunol. 138:1762-1771.
20. Bieber, T., et al. 1992. Human Langerhans cells express the high affinity receptor for IgE (FcεRI). J. Exp. Med. 175:1285-1290.
21. Dibbert, B., et al. 1998. Role for Bcl-x in delayed eosinophil apoptosis mediated by granulocyte-macrophage colony-stimulating factor and interleukin-5. Blood. 92:778-783.
22. Kiener, P.A., et al. 1997. Differential induction of apoptosis by Fas-Fas-ligand interactions in human monocytes and macrophages. J. Exp. Med. 185:1511-1516.
23. Lomo, J., et al. 1997. Interleukin-13 in combination with CD40 ligand potently inhibits apoptosis in human B lymphocytes: upregulation of Bcl-xL and Mcl-1. Blood. 89:4415-4424.
24. Ando, T., et al. 1998. The possible role of apoptosis-suppression genes. Bcl-2 and Mcl-1/EAT in human adrenal tumors. Endocr. Res. 24:955-960.
25. Sanz, C., et al. 1997. The expression of Bcl-x is down-regulated during differentiation of human hematopoietic progenitor cells along the granulocytes but not the monocyte/macrophage lineage. Blood. 89:3199-3204.
26. White, E. 1996. Life, death, and the pursuit of apoptosis. Genes Dev. 10:1-15.
27. Kroemer, G. 1997. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat. Med. 3:614-620.
28. Boise, L.H., et al. 1993. Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell. 74:597-608.
29. Okamura, H., et al. 1995. Cloning of a new cytokine that induces IFN-γ production by T cells. Nature. 378:88-91.
30. Yoshimoro, T., Okamura, H., Tagawa, Y.I., Iwakura, Y., and Nakanishi, K. 1997. Interleukin 18 together with interleukin 12 inhibits IgE production by induction of interferon-gamma production from activated B cells. Proc. Natl. Acad. Sci. USA. 94:3948-3953.
31. Estaquier, J., and Ameisen, C. 1997. A role for T-helper type-1 and type-2 cytokines in the regulation of human monocyte apoptosis. Blood. 90:1618-1625.
32. Leung, D.Y.M. 1995. Atopic dermatitis: the skin as a window into the pathogenesis of chronic allergic disease. J. Allergy Clin. Immunol. 96:302-319.
33. Cooper, K. 1994. Atopic dermatitis: recent trends in pathogenesis and therapy. J. Invest. Dermatol. 102:128-137.
34. Bieber, T. 1997. FcεRI expressing antigen presenting cells: new players in the atopic game. Immunol. Today. 18: 311-313.
35. Hanifin, J.M., and Chan, S.C. 1995. Monocyte phosphodiesterase abnormalities and dysregulation of lymphocyte function in atopic dermatitis. J. Invest. Dermatol. 105:84-88.
36. Van Antwerp, D.J., Martin, S.J., Kafri, T., Green, D.R., and Verma, I.M. 1996. Suppression of TNF-alpha-induced apoptosis by NF-κB. Science. 274:787-789.
37. Dixon, E.P., Stephenson, D.T., Clemens, J.A., and Little, S.P. 1997. Bcl-Xshort is elevated following severe global ischemia in rat brains. Brain Res. 776:222-229.
38. Lee, H.H., Dadgostar, H., Cheng, Q., Shu, J., and Cheng, G. 1999. NF-κB mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes. Proc. Natl. Acad. Sci. USA. 96:9136-9141.
39. Tamatani, M., et al. 1999. Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NF-κB activation in primary hippocampal neurons. J. Biol. Chem. 274:8531-8538.
40. Krajewski, S., et al. 1995. Immunohistochemical analysis of Mcl-1 protein in human tissues. Differential regulation of Mcl-1 and Bcl-2 protein production suggests a unique role for Mcl-1 in control of programmed cell death in vivo. Am. J. Pathol. 146:1309-1319.
41. Kapsenberg, M.L., Hilkens, C.M.U., Wierenga, E.A., and Kalinski, P. 1998. The role of antigen-presenting cells in the regulation of allergen-specific T cell responses. Curr. Opin. Immunol. 10:607-613.
42. Grewe, M., et al. 1998. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol. Today. 8:359-361.
43. Leung, D.Y.M., Schneeberger, E.E., Siraganian, R.P., Geha, R.S., and Bhan, A.K. 1987. The presence of IgE on macrophages and dendritic cells infiltrating into the skin lesion of atopic dermatitis. Clin. Immunol. Immunopathol. 42:328-337.
44. Klubal, R., et al. 1997. The high affinity receptor for IgE is the predominant IgE-binding structure in lesional skin of atopic dermatitis patients, J. Invest. Dermatol. 108:336-342.
45. Wollenberg, A., Kraft, S., Hanau, D., and Bieber, T. 1996. Immunomorphological and ultrastructural characterization of epidermal Langerhans cells and a novel, inflammatory dendritic cell (IDEC) population m lesional skin of atopic eczema. J. Invest. Dermatol. 106: 446-453.
46. Valenta, R., et al. 1998. Molecular characterization of an autoallergen, Hom s 1, identified by serum IgE from atopic dermatitis patients. J. Invest. Dermatol. 111:1178-1183.
47. Sutton, B.J., and Gould, H.J. 1993. The human IgE network. Nature. 366:421-428.
48. Quinti, I., Brozek, C., Geha, R.S., and Leung, D.Y.M. 1986. Circulating IgG antibodies to IgE in atopic syndromes. J. Allergy Clin. Immunol. 77:586-594.